AXTA: Is It Time for a Put Play? AI Bearish Signal

Axalta is a global manufacturer of high-performance coatings systems. Its core business is divided into two segments: Performance Coatings and Mobility Coatings. Performance Coatings serves the refinish and industrial end-markets, offering brands like 'Cromax', 'Standox', and 'Spies Hecker' for automotive repair, and 'Imron Industrial' and 'Alesta' for various industrial applications. Target customers include body shops, industrial manufacturers, and construction companies. Mobility Coatings provides coatings for light and commercial vehicle OEMs, featuring 'AquaEC', 'HyperDur', 'ChromaDyne', and 'Lumeera'. Axalta differentiates itself by offering color matching technology, sustainable solutions, and technical expertise, focusing on enhancing performance, appearance, and durability while improving customer productivity.

No relevant news was found for this stock today.

AXTA's technical indicators paint a bearish picture for the next 1-3 months. The stock is trading at $27.555, significantly below its 50-day SMA of $29.34 and its 200-day SMA which is unavailable but would be significantly higher, confirming a downtrend. The EMA_21 at 28.58 is also above the current price, suggesting continued downward pressure. Momentum indicators further support this bearish outlook. The MACD at -0.017 is below its signal line, and both MACD and signal are negative, suggesting a continuation of the downward trend. The RSI_14 is at 44.72, indicating weakening momentum and approaching oversold conditions, but not there yet. The STOCHk is 41.41 and STOCHd is 55.17, also trending down. The ROC_20 is negative at -0.28. The ADX_14 is at 19.06, suggesting the downtrend may not be very strong, but still present. Recent price action confirms a sharp decline, with the price failing to sustain any rallies. The BBP is at 0.49, which confirms the price is trending towards the lower Bollinger Band. Overall, the combination of price action below key moving averages and bearish momentum indicators suggests a likely continuation of the downtrend in the near term.

Axalta's MD&A presents a mixed financial performance. `Net sales` for the three months ended September 30, 2025, decreased by 2.4% to $1,288 million, compared to $1,320 million in 2024. This decrease was primarily driven by lower sales volumes in the Performance Coatings segment. The `Gross Profit` margin can be derived from the data provided. For the three months ended September 30, 2025, the gross profit margin was 34.9% (Net sales of $1,288 million less Cost of sales of $838 million, divided by Net sales of $1,288 million). For the three months ended September 30, 2024, the gross profit margin was 35.0% (Net sales of $1,320 million less Cost of sales of $858 million, divided by Net sales of $1,320 million). `Net cash provided by operating activities` for the nine months ended September 30, 2025, was $305 million, a decrease compared to $342 million for the same period in 2024. The decrease was driven by net uses of working capital of $315 million. Management believes that 'cash flow from operations, available cash on hand and available borrowing capacity under our Senior Secured Credit Facilities and other existing lines of credit will be adequate to service debt, fund our cost saving initiatives, meet liquidity needs and fund necessary capital expenditures for the next twelve months'. The company repurchased 5.3 million shares for $165 million and prepaid $10 million of debt, signaling confidence, but the decline in sales and operating cash flow warrant caution.

Axalta's Q2 2025 earnings call reveals a mixed but cautiously optimistic outlook. The company achieved 'a record quarter for adjusted EBITDA and adjusted diluted earnings per share,' despite a 'challenging global market'. Net sales aligned with guidance at just over $1.3 billion, while adjusted EBITDA reached $292 million with margins exceeding 22%. Management acknowledges 'temporary challenges' in the North American Refinish market, citing lower collision claims due to factors like elevated repair costs and rising insurance premiums. Net sales in Refinish declined 6% year-over-year, but there was nearly 2% growth from adjacencies and retail. The company is revising its full-year net sales guidance to $5.2 billion - $5.275 billion, representing an approximate 1% decline year-over-year. However, adjusted EBITDA margins are expected to remain around 22% or above, with adjusted EBITDA projected between $1.14 billion and $1.165 billion. Management maintains a confident tone, emphasizing their 'A Plan' strategy and the potential for industry stabilization and increased consumer confidence leading to a more favorable repair environment. They expect revenue to 'inflect positively' in the fourth quarter and into next year.

AXTA's financial performance presents a mixed but slightly positive picture. Revenue has generally increased, starting from $1,294,000,000 in Q1 2024 and reaching $1,288,000,000 in Q3 2025, although there's a slight dip in the most recent quarter. Gross profit margins have fluctuated, ranging from 0.324 to 0.35, indicating some variability in profitability. The company generated positive operating cash flow of $34,000,000 in Q1 2024 and $142,000,000 in Q2 2025 but shows $0 operating cash flow in Q3 2025, raising concerns about consistent cash generation. Total debt decreased from $3,521,000,000 in Q4 2024 to $20,000,000 in Q3 2025, a significant reduction that strengthens the balance sheet. Overall, while revenue and profitability show some inconsistencies, the significant debt reduction and generally positive cash flow suggest a moderately stable outlook for the next 6-12 months.

The company demonstrates a moderately bullish profile, characterized by solid revenue growth and improving profitability. Revenue has consistently increased, indicating strong market demand. The gross margin exhibits stability, suggesting efficient cost management. Return on Equity (ROE) has shown positive movement, signaling enhanced profitability and efficient use of shareholder equity. The Price-to-Earnings (P/E) ratio, while elevated, might be justifiable given the growth trajectory and positive ROE trend. The Debt-to-Equity ratio shows a slight increase, which warrants monitoring, but is counterbalanced by a healthy Current Ratio, implying sufficient liquidity to meet short-term obligations. Overall, the company presents a favorable picture with growth and profitability, though the leverage should be watched closely. The combination of growth and profitability suggests potential for continued positive performance over the next 12 months.